Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win

Non-Polyp Rhinosinusitis Targeted Initially

 
• By Sushmita Panda
  
Lyra Therapeutics
Lyra Eyes US Filing For Drug-Eluting Implant For Non-Polyp Rhinosinusitis (Shutterstock)

More from Clinical Trials

More from Scrip